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Rab proteins typically lack the consensus carboxyl- 
terminal CXXX motif that signals isoprenoid modifi- 
cation of Ras and other isoprenylated proteins and, 
instead, terminate in either CC or CXC sequences (C = 
cysteine, X = any amino acid). To compare the func- 
tional relationship between the Ras CXXX and the Rab 
CC/CXC motifs, we have generated chimeric Ras pro- 
teins terminating in Rab carboxyl-terminal CC or CXC 
sequences. These mutant Ras proteins were not iso- 
prenylated in  vitro or in  vivo, demonstrating that the 
CC and CXC sequences alone are not sufficient to re- 
place a CXXX sequence to signal Ras isoprenoid mod- 
ification. Surprisingly, chimeric Ras/Rab proteins ter- 
minating in significant lengths of carboxyl-terminal 
sequences from Rablb  (7-139 residues), Rab2 (5-151 
residues), or Rab3a (12 residues) were also not iso- 
prenylated. These results demonstrate that the se- 
quence requirements for isoprenoid modification of 
Rab proteins are more complex than the simple tetra- 
peptide CXXX sequence for isoprenoid modification of 
Ras proteins and suggest that the Rab geranylgeranyl 
transferase(s) requires recognition of protein confor- 
mation to signal the addition of geranylgeranyl groups. 
Finally, competition studies demonstrate that a com- 
mon geranylgeranyl transferase activity is responsible 
for the modification of Rab proteins terminating in CC 
or CXC motifs. 
Recent  studies  have  established  that a  diverse class of yeast 
and mammalian  proteins undergoes covalent modification by 
isoprenoid  addition  and  that  the  functions of these  proteins 
are likely to be critically dependent  on  these modifications 
(1-3). The  Ras oncogene proteins  are  the  best  characterized 
isoprenylated  proteins  and provide an  excellent  prototype for 
understanding  the role of prenylation  in  protein  function (3- 
5). All Ras  proteins  terminate  in a consensus carboxyl-ter- 
minal  CXXX  (C = cysteine, X = any  amino  acid) motif  which 
signals  the  addition of a 15 carbon  farnesyl  isoprenoid,  as well 
as two other closely linked posttranslational modifications 
(proteolytic removal of the XXX residues and carboxyl meth- 
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ylation of the  farnesylated  cysteine).  These CXXX-signaled 
modifications are  critical for Ras association  with the plasma 
membrane  and for Ras  transforming  activity (4-6). 
The importance of the  CXXX motif  for  isoprenoid modifi- 
cation of Ras  proteins  has  been  demonstrated by several  lines 
of study.  First,  mutant  Ras  proteins lacking either  the cysteine 
or the XXX residues of the CXXX motif are completely 
blocked in isoprenoid modification (7-9). Second, synthetic 
tetrapeptides  corresponding  to  the  CXXX sequences of the 
Ras  proteins  are  both efficient competitors of, and  substrates 
for,  Ras  farnesyl  transferase  activity (10-12). Third,  the  in- 
troduction of the H-Ras CXXX tetrapeptide sequence to 
heterologous proteins  such  as  protein A or  the a subunit of 
the heterotrimeric Gi protein results in the prenylation of 
these  normally  nonprenylated  proteins (8, 13). Therefore,  the 
CXXX  tetrapeptide sequence is  not only  required but  is also 
sufficient to  signal for  isoprenoid  modification of Ras  proteins 
and  other  isoprenylated  proteins. Finally, the  last residue of 
the  CXXX sequence dictates  the specific modification of the 
CXXX-containing  proteins by different  prenyl  transferases 
which specifically promote  the  addition of either  farnesyl or 
geranylgeranyl  moieties (11, 14-16). 
Although the  Rab/YPT family of Ras-related  proteins rep- 
resents a major group of isoprenylated proteins (1, 17-20), 
most lack carboxyl-terminal  CXXX sequences, and  instead, 
typically terminate in either CC or CXC  motifs (21-23). 
Mutant  Rab  proteins  lacking  their  carboxyl-terminal CC or 
CXC sequences are  not modified by prenylation (11,  18, 24- 
26), are cytosolic and lack biological activity. Thus  the CC 
and CXC  motifs are  functionally analogous to  the  Ras  CXXX 
motif and  are  critical for the  posttranslational processing and 
subcellular  localization of Rab  proteins. 
Biochemical and genetic evidence indicates that proteins 
terminating  in CC/CXC  sequences are modified by a geran- 
ylgeranyl transferase(s) that is distinct from the activities 
that modify proteins terminating in CXXX sequences (11, 
27-29). Furthermore, since the terminal 3 residues of the 
CXXX motif are  critical  to  signal isoprenoid  modification of 
Ras  proteins (11,30), it  is also clear  that  the sequence  require- 
ments for Rab isoprenoid  modification are  distinctly  different 
from  the sequences recognized by the  CXXX  prenyl  transfer- 
ases. Finally, the CC and CXC motifs signal modifications 
distinct  from  those signaled by CXXX sequences. The CXC 
motif of Rab3a  has  been shown to be modified by two geran- 
ylgeranyl  moieties (17) and by carboxyl methylation (17,  31). 
The CC motif is modified by at  least one, or possibly two, 
geranylgeranyl isoprenoids (18, 20, 32) but is not carboxyl- 
methylated (20,31). Thus  the CC and  CXC sequences contrast 
with the CXXX sequences, and with each other, signaling 
structurally  distinct  carboxyl-terminal modifications. 
Recent evidence implicates mammalian Rab proteins as 
critical regulatory elements in intracellular trafficking (26, 
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33). The localization of different Rab proteins at distinct 
intracellular  membrane  compartments of the endocytic and 
exocytic pathways  (3,34)  is  consistent  with  this  function. For 
example,  the  Rablb  protein  has  been localized to  the  endo- 
plasmic reticulum and Golgi (33), while Rab3a protein is 
associated  with secretory vesicles (35, 36). Thus, current 
models suggest that each Rab protein interacts with two 
distinct membrane subcompartments and reversibly cycles 
between cytosolic and  membrane  fractions  (34,37).  While  the 
functional distinction between the CXXX, CC, and CXC 
motifs is presently  not  known,  it  has been demonstrated  that 
the CC/CXC carboxyl-terminal sequences are  critical  for  Rab 
function  in regulating  vesicular trafficking  in endocytosis and 
exocytosis (24-26), and  it  is possible that  this  function may 
not be replaced by the carboxyl-terminal CXXX-signaled 
modifications. 
Since  proteins  terminating  in  CXXX uersus CC/CXC se- 
quences undergo different modifications that  are  catalyzed by 
different enzymes, we have initiated  studies  to  determine  the 
Rab sequences  required to  signal isoprenoid  modification and 
t o  determine whether CXXX, CC, and CXC motifs have 
different  functional roles. Our  results  demonstrate  that  the 
CC/CXC sequences cannot  functionally replace the  Ras 
CXXX sequence to  promote  Ras processing and  membrane 
association, that additional upstream sequences as well as 
protein  conformation seem to play a critical role in  prenyla- 
tion of the  Rab  proteins,  and finally, that  proteins  terminating 
in CC or CXC  sequences are modified  by a common  geranyl- 
geranyl  transferase activity. 
EXPERIMENTAL  PROCEDURES 
Generation of Ras and  Rab Carboxyl-terminal Mutants  and Ras/ 
Rab Chimeric  Proteins-Oncogenic H-Ras(61-Leu)  or  Rablb  mutant 
sequences that encode carboxyl-terminal mutants (Table I) were 
generated by oligonucleotide-directed mutagenesis using Taq polym- 
erase  chain reaction  DNA amplification  as described  previously (18). 
H-raslrablb,  H-raslrab2,  and  H-raslrab3a  chimeric genes were con- 
structed using polymerase chain  reaction  amplification to  generate 
specific DNA fragments from H-ras, rablb, rab2, and rab3a cDNA 
sequences using pairs of oligonucleotides to  introduce  the  appropriate 
restriction  sites at  the  5'-  and  3'-ends of the  resulting DNA fragments 
(see Fig. 3).  The  resulting  fragments were introduced  into  either  PAT- 
RasH  (Ras  and  Ras/Rab  chimeras)  or  pET3a  (Rab)  bacterial  expres- 
sion vectors (38, 39). All sequences  were  verified  by  dideoxy sequenc- 
ing  (40). Ras, Rab,  or  Ras/Rab  proteins were expressed  and isolated 
from Escherichia coli strains PR13-Q or BL-21(DE3) as described 
previously (18). The  mutant  and chimeric  genes were also  introduced 
into  the  pZIP-NeoSV(X)l  retrovirus vector for expression in  mam- 
malian cells (41). 
I n  Vitro Protein  Prenylation Assays-Specific prenylation of bac- 
terially expressed Rablb  carboxyl-terminal  mutants,  H-Ras carboxyl- 
terminal  mutants,  and  H-Ras/Rablb  chimeras were determined  using 
a n  in vitro rabbit reticulocyte lysate  prenylation  system  as described 
previously (18). Purified  proteins (1.2 p ~ )  were incubated  in a final 
volume of 50 p1 with  nuclease-treated reticulocyte lysate  (Promega) 
TABLE I 
H-ras and  rablb carbox.yl-terminal mutants 
Protein Carboxyl-terminal 'H incorporation sequence MVA GGPP FFPP 











SGPGCMSCKCVLS + - + 
SGPGCMSCKC--- - - - 
SGPGSMSSKCC-- 
SGPGSMSSKCS- 
- - - 
- - - 
TPVKSASGGCC i- + - 
TPVKSASGG" 
TP"-----CC 




TPVKSASGGCE + + 
TPVKSASGGCVIM + + + 




in  the presence of 5 p~ [3H]farnesyl pyrophosphate  (FPP)' (2.5 Ci/ 
mmol) (Du Pont-New England Nuclear), 5 p~ [3H]geranylgeranyl 
pyrophosphate  (GGPP; 2.5 Ci/mmol)  (University of South  Florida), 
or 40 p~ [3H]MVA (lactone form; Du  Pont-New  England  Nuclear) 
(24 Ci/mmol).  Incubations were conducted a t  30 "C for 1 h,  and  the 
reactions were stopped by addition of an equal volume of 2 X sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis  (SDS-PAGE)  sam- 
ple  buffer and analyzed  by SDS-PAGE  and fluorography. The  Rablb 
carboxyl-terminal  mutants were also incubated  with  partially purified 
YPTl  geranylgeranyl transferase activity (designated GGTase 11; 
provided  by J. Gibbs, Merck  Sharp  and Dohme Laboratories,  West 
Point,  PA) (11) in  the presence of [3H]GGPP,  and [3H]GG incorpo- 
ration was visualized  by SDS-PAGE  and fluorography. 
Guanine Nucleotide Binding Assays-Two approaches were used 
to establish the ability of each Ras/Rab chimeric protein to  bind 
GTP efficiently. First, 10 p1 of purified  bacterially  expressed proteins 
(50 pg/ml) were incubated  in a 50-p1 reaction  with 25 mM HEPES 
(pH 8.0) and 1 mM DTT,  in  the  presence of 0.1 p~ [y-35S]GTP (800 
Ci/mmol; Du  Pont-New  England  Nuclear) for  10 min at  30 "C. Each 
reaction was then  stopped by adding 1 ml of 25 mM Tris  (pH 8.0), 
100 mM NaCl, 30 mM MgC12,2 mM dithiothreitol,  and 1 mg/ml  bovine 
serum  albumin. The  amount of bound  [Y-~'SS]GTP was  measured by 
vacuum filtration  and liquid scintillation  counting  (42). Second,  bac- 
terially  expressed proteins were separated by SDS-PAGE  and  trans- 
ferred to nitrocellulose filters,  then  incubated  with 1 p~ [y3'S]GTP 
in  50 mM Tris, 0.3% Tween, 0.5 mM EDTA, 0.5 mM MgCl', and  10 
pM of GTP (43). The bound ["SIGTP  was then visualized by fluo- 
rography. 
Characterization of Isoprenylation of Ras/Rab  Chimeric Proteins  in 
Vivo-NIH 3T3 mouse fibroblasts were transfected by the calcium 
phosphate precipitation technique (44), and transfected cells were 
isolated by selection  in Dulbecco's modified  Eagle's  medium supple- 
mented  with 10% calf serum  and 400 pg/ml  G418 (Geneticin, 
GIBCO). NIH 3T3 cells expressing H-Ras/Rab chimeric proteins 
were established by cotransfection with an oncogenic c-raf cDNA 
plasmid  construct.  Details of the  establishment of these cells will be 
described elsewhere.' NIH  3T3 cells expressing  each  mutant  H-Ras 
and H-Ras/Rab protein were metabolically labeled for 16-18 h a t  
37 "C  in Dulbecco's modified  Eagle's  medium supplemented  with 10% 
dialyzed calf serum  and ['HIMVA at 100 pCi/ml  or  [35SJmethionine/ 
cysteine  (Met/Cys;  Translabel,  ICN  Pharmaceuticals) a t  100 pCi/ml. 
Fractionation into crude membrane (P100) and cystosolic (S100) 
fractions  and  partitioning  into  Triton X-114 were done as described 
previously (18). H-Ras and chimeric Ras/Rab proteins were then 
immunoprecipitated  with  the Y13-259 (45)  and  Rasll  (46)  anti-Ras 
monoclonal antibodies  and  analyzed by SDS-PAGE  and fluorogra- 
phy. 
Selective Inhibition of Protein  Prenylation by Proteins with Differ- 
ent Carboxyl-terminal Motifs-To determine if proteins  with  distinct 
carboxyl-terminal  motifs  are modified by shared  prenyl  transferase 
activities, 0.75-1.0 p~ of bacterially expressed H-Ras, G25K, Rablb, 
and  Rab3a were each  incubated  with  nuclease-treated  rabbit  reticu- 
locyte lysate and [3H]FPP (for H-Ras) or ['HH]GGPP (for G25K, 
Rablb, and Rab3a) alone, or in the presence of a >lO-fold molar 
excess  (10 p ~ )  of the  competing  protein  or  peptide  substrate. Reac- 
tions were done for 1 h at  30 "C,  and  the  proteins were then resolved 
on SDS-PAGE, and fluorographed after treatment with Amplify 
(Amersham). The gel slices containing  the labeled proteins were also 
treated  with H'O, to release the labeled material which was quantified 
by liquid scintillation as described previously (10, 18). The G25K 
bacterial expression construct was provided by R. Cerione (Cornel1 
University, Ithaca,  NY)  (47). 
RESULTS 
Rab CC or CXC Sequences Are Necessary but  Not  Sufficient 
for Rab  Isoprenylation-In order  to  determine  the carboxyl- 
terminal sequence requirements for Rab isoprenylation, we 
generated Ras or Rablb mutant proteins with altered car- 
boxyl-terminal sequences (Table I). Bacterially expressed  mu- 
tant  proteins were then  incubated  with  either  rabbit  reticu- 
' The abbreviations used are: FPP, farnesyl pyrophosphate; ER, 
endoplasmic  reticulum; GGPP, geranylgeranyl pyrophosphate; MVA, 
mevalonate;  PAGE, polyacrylamide gel electrophoresis; GTPyS, 
guanosine 5'-3-0-(thio)triphosphate. 
G. J. Clark,  R.  Khosravi-Far,  and C. J. Der, manuscript  in 
preparation. 
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locyte lysate or partially purified geranylgeranyl transferase 
(designated GGTase 11) and [3H]MVA to determine  prenyla- 
tion efficiency in vitro. In  contrast  to  the wild type H-Ras 
protein, mutant  H-Ras proteins that  terminate in either CC 
or CSC sequences were not prenylated in vitro (Table I). 
Furthermore, analysis of NIH  3T3 cells expressing the  mutant 
proteins also failed to demonstrate  incorporation of [3H]MVA 
in vivo (data not shown). Consistent with the absence of 
isoprenylation, fractionation analysis demonstrated that, like 
the nonprenylated H-Ras(AVLS) mutant,  the CC and CSC 
mutant proteins were located exclusively in the cytosolic 
(SlOO) fraction (Fig. 1). Thus  the  Rab CC or CXC sequences 
alone  cannot replace the  Ras CXXX sequence to promote  Ras 
isoprenylation and membrane association in vivo. 
While a Rablb  mutant protein lacking both carboxyl-ter- 
minal cysteine residues (Rablb(ACC)) was not a substrate for 
isoprenylation in vitro, mutant Rablb proteins  retaining 
either cysteine residue (Rablb(CS) and Rablb(SC)) were 
radiolabeled with both [3H]MVA and [3H]GGPP (Fig. 2). 
These results suggested that  both cysteines may  be  modified 
by isoprenoid addition and  that  the CC motif, like the CXC 
motif, may also signal modification by two geranylgeranyl 
" 
WT AVLS E 
S P  S P  S P  S P  
a b  C d   e f  g h  
FIG. 1. Localization of mutant Ras proteins terminating 
with CC or CXC sequences. NIH 3T3 cells expressing H-Ras wild 
type (lanes  a and b )  or mutant proteins, either lacking the  terminal 
3 residues (designated AVLS; lunes c and d )  or terminating in CC 
(lunes  e and f )  or CSC (lanes g and h)  residues, were metabolically 
labeled with [:"S]Met/Cys for 16 h. The overexpressed proteins were 
then fractionated into crude cytosolic ( S )  and particulate (P) frac- 
tions and immunoprecipitated with anti-Ras Y13-259 monoclonal 
antibody. Proteins were then separated by SDS-PAGE  and visualized 
by fluorography. 
WT ACC cs sc CKC 
M F G G  M F GG M F GG M F GG M F GG 
a b c  d e f  g h i  j k t  m n o  
FIG. 2. In vitro prenylation analysis of Rablb carboxyl- 
terminal mutant proteins. I n  vitro isoprenoid modification of 
bacterially expressed carboxyl-terminal mutant proteins of Rablb 
was analyzed in an in vitro rabbit reticulocyte lysate prenylation 
system in the presence of ["HJMVA (M), ['HJFPP ( F ) ,  or ["HJGGPP 
(CC) as described under  "Experimental Procedures." Lysates incu- 
bated with wild type Rablb (lunes a-c), Rablb(ACC) (lunes d-f), 
Rablb(CS) (lanesg-i), Rablb(SC) (lanesj-l), or Rablb(CKC) (lanes 
rn-o) were resolved on SDS-PAGE and analyzed by fluorography. 
We have previously shown that in  vitro ["HIMVA-labeled Rablb 
proteins  are modified by geranylgeranyl moieties (18). 
moieties. In addition, the reduced incorporation of [3H] into 
these two mutant proteins, when compared to  the wild type 
protein,  demonstrates that both cysteine residues are required 
for optimal  prenylation of Rablb. A Rablb  mutant protein 
that retains the double cysteines, but lacks 7 amino acids 
upstream from the cysteine residues (Rablb(A7)CC), was not 
isoprenylated in  vitro (Table  I). Thus,  Rablb isoprenylation 
is dependent on both the CC motif and sequences upstream 
of these cysteine residues. Finally, Rablb mutant protein 
terminating  in either CXC (CKC or CSC) (Table  I and Fig. 
2, lanes m-o) or CXXX (CVLS) (Table I) sequences were also 
efficiently isoprenylated in uitro, indicating that  Rablb car- 
boxyl-terminal sequences upstream of the CC motif are com- 
patible with these two different prenylation signal sequences. 
Rab Geranylgeranyl  Transferases May Require Recognition 
of Protein  Conformation  for Isoprenylation-To determine the 
carboxyl-terminal sequence requirements for isoprenoid mod- 
ification of Rab  proteins, we generated a series of Ras/Rab 
chimeric proteins that contain the amino-terminal sequences 
of H-Ras but in which varying lengths of Rablb (7-139 
residues), Rab2 (5-151 residues), or Rab3a (12 residues) re- 
placed the carboxyl-terminal region of H-Ras (Fig. 3). Sur- 
prisingly, none of these chimeric proteins was isoprenylated 
in vitro when incubated with reticulocyte lysate (representa- 
tive examples are shown in Fig.  4, lanes d, f, and i )  or partially 
purified GGTaseII (data not shown). Analysis of these chi- 
meric Ras/Rab  proteins  in  transfected NIH  3T3 cells dem- 
onstrated that these mutant proteins, in contrast to H- 
Ras(GlL), were not metabolically labeled with [3H]MVA,  were 
present exclusively in  the crude cytosolic (SlOO) fraction (Fig. 
5A), and did not partition into the detergent phase after 
Triton X-114 extraction (Fig. 5B).  Thus, despite possessing 
significant carboxyl-terminal sequences from Rab proteins, 
these chimeric proteins were still  not  substrates for isopren- 
ylation i n  vitro or in vivo. 
The lack of isoprenoid modification of the Ras/Rab chi- 
meric proteins suggested that Rab carboxyl-terminal se- 
quences alone are  not sufficient for Rab geranylgeranyl trans- 
ferase modification. Alternatively, the improper folding of the 
combined amino-terminal Ras and carboxyl-terminal Rab 
sequences, or the inaccessibility of the carboxyl termini  to the 
prenyl  transferase, may account for the lack of efficient iso- 
prenoid modification of these chimeric proteins. To address 
the first possibility, we analyzed these chimeric proteins for 
their ability to bind  [35S]GTPyS. Bacterially expressed chi- 
meric Ras/Rab proteins were analyzed by incubation with 
M [35S]GTPyS, followed by vacuum filtration through 
nitrocellulose filters, or by separation on SDS-PAGE and 
transfer  to nitrocellulose followed by incubation with [3sS] 
GTPyS. Like authentic H-Ras, Rablb,  and Rab2 proteins, 
all chimeric Ras/Rab  proteins efficiently bound [3sS]GTPrS 
(data  not shown), indicating that they were properly folded 
to produce a  functional conformation. To address the possi- 
bility that  the carboxyl-terminal sequences were not available 
for isoprenylation, we generated chimeric Ras/Rablb proteins 
which terminated in CVIM instead of in CC residues. In 
contrast  to  their non-CXXX  containing  counterparts, both 
the Ras/Rablb.l5(CVIM) and Ras/Rablb.33(CVIM) chi- 
meric proteins were good substrates for isoprenylation (Fig. 
4, lanes g and h),  indicating that their carboxyl-terminal 
regions were accessible for isoprenoid addition. Furthermore, 
both Ras/Rablb.l5(CVIM) and Ras/Rablb.33(CVIM) dis- 
played potent transforming activity when expressed in NIH 
3T3 cells (data  not shown), which provides further indication 
that these chimeric proteins  are properly folded. 
Crystal structure determination of the  H-Ras protein dem- 
onstrated that the amino and carboxyl-terminal sequences 
reside on the same face of the protein (48,49). Therefore, we 
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FIG. 3. Structure of chimeric Ras/ 
Rab proteins. Proteins encoded by mo- 
lecular  constructs  containing H-Ras 
(shaded  boxes), Rablb (bold hatched 
boxes), Rab2 (light hatched bones), and 
Rab3a (black boxes) sequences are 
shown. The carboxyl-terminal residues 
of H-Ras were replaced by 7 to 139 car- 
boxyl-terminal residues from Rablb (c- 
g), 5 to 151 carboxyl-terminal residues 
from Rab2 (i-m),  or 12  carboxyl-termi- 
nal residues from Rab3a ( p ) .  The num- 
bers after each chimera  indicate the 
number of amino acids from carboxyl- 
terminal of Rab proteins that replace 
analogous amino acids from H-Ras. In 
addition,  a  RabS/Ras/Rab2  chimera ( n )  
was generated which contains  the first 
60 amino-terminal residues of Rab2 fol- 
lowed by H-Ras residues 61-160 and  ter- 
minates with the 65 carboxyl-terminal 
amino acids of Rab2. 
a b c d e f  
a. ras 
b. rablb 
c. ras/rabl b.7 





i .  rashab2.5 
j. rashab2.11 
k. rashab2.25 





g h i  
FIG. 4. In vitro prenylation of Ras/Rab chimeras. The iso- 
prenoid modification of Ras/Rab recombinant proteins was analyzed 
in  the rabbit reticulocyte lysate  system in  the presence of t3H]MVA 
followed by SDS-PAGE  analysis as described under  “Experimental 
Procedures.” Lane a, H-Ras (WT); lane b, Rablb; lune c, Rab3a; lune 
d, Ras/Rablb.33; lune e, Ras/Rab2.11; lune f, Rab2/Ras/Rab2; lune 
g, Ras/Rablb.l5 CVIM; lune h, Ras/Rablb.33 CVIM, and lane i, 
Ras/Rab3a.l2. 
A. 8. 
ras6lL raOlrabib.14 nshab2.25 
”-
ras WT raOlfablb.33 raOlrab2.25 
”-
S P  S P  S P  D A   D A  D A  
-. . - . ”. 
4 I mS. - ”p.  ---. rnS,,&
\ .  
a b c d  e t  a b  E d  e l  
FIG. 5. In vivo prenylation of Ras/Rab chimeras. NIH  3T3 
cells expressing each  Ras/Rab chimeric protein (in  the presence of 
oncogenic c-raf) were labeled with [3sS]Met/Cys. Cells expressing 
Ras(61L or WT) (lanes  u and b) ,  Ras/Rablb.ll (lanes  c and d ) ,  or 
Ras/Rab2.25 (lunes  e and f) were ruptured and fractionated (Panel 
A ) into crude cytosolic (5’) and membrane-containingparticulate ( P )  
fractions, or lysed (Panel B )  in 1% Triton X-114 and partitioned into 
detergent-depleted, aqueous ( A ) ,  and detergent-enriched (D) phases. 
The recombinant  proteins were then immunoprecipitated by a pool 
of Y13-259 and Rasl l  anti-ras monoclonal antibodies. Membrane 
association and prenylation were analyzed by SDS-PAGE and visu- 
alized by fluorography. Arrows to  the left show H-Ras (WT), and 
arrows to  the right show the chimeric Ras/Rab  proteins. 
Modification of Rab Proteins Terminating with CC or CXC 
Sequences-To further characterize the prenyl transferase 
activities responsible for the isoprenylation of proteins ter- 
minating in CXXX, CC, or CXC sequences, we performed 
competition experiments to measure the ability of heterolo- 
gous peptides or proteins to block isoprenylation of bacterially 
expressed H-Ras (carboxyl-terminal CXXX motif for farne- 
sylation), G25K (carboxyl-terminal CXXX motif  for geran- 
ylgeranylation), Rablb (CC), or Rab3a (CXC) proteins using 
the reticulocyte lysate assay (Fig. 6). For each assay 1 pM of 
each substrate protein was incubated either alone, or in the 
presence of a 10-fold molar excess of the competing peptide 
or protein, and  the incorporation of either [3H]FPP or [3H] 
GGPP  into  the  substrate protein was determined. 
H-Ras isoprenylation was selectively inhibited by a syn- 
thetic peptide corresponding to  the carboxyl terminus of the 
farnesylated yeast a-factor (CVIA) (50), but not by full length 
G25K (CVIF), Rablb (CC), or Rab3a (CSC) protein (Fig. 6A). 
Similarly, G25K isoprenylation was inhibited by a synthetic 
heptapeptide corresponding to  the carboxyl terminus of the 
geranylgeranylated 7 - 6  subunit of heterotrimeric G proteins 
(KFFCAIL) (16,51,52),  but  not by full length H-Ras, Rablb, 
or Rab3a protein (Fig. 6B). In contrast to the ability of 
CXXX-containing peptides to efficiently inhibit the isopren- 
ylation of Ras or G25K proteins, Rablb  and Rab3a peptides 
corresponding to  the  last 8 carboxyl-terminal amino acids of 
these proteins did not inhibit the isoprenylation of either 
Rablb or Rab3a when used at  peptide concentrations of up 
to 50 p~ (data not shown). These data, together with the 
inability of the chimeric Ras/Rab  proteins to serve as efficient 
substrates for isoprenylation, provide further evidence that 
Rab prenyl transferase(s) requires recognition of Rab se- 
quences distant from the carboxyl termini. 
To determine if Rablb  and Rab3a are modified by distinct 
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FIG. 6. Selective inhibition of Ras and Rab isoprenylation 
in vitro. Substrate proteins were  incubated at a concentration of 1 
p~ with reticulocyte lysate and [3H]FPP (for H-Ras) or [3H]GGPP 
(for G25K, Rablb, and Rab3a) in the presence of 10 p~ inhibitor 
protein. Following incubation, proteins were resolved on SDS-PAGE, 
and incorporation of activity was determined as described under 
“Experimental Procedures.” Results are expressed as means of dupli- 
cate determinations. Substrate (1 p ~ )  is as follows: A, H-Ras; B, 
G25K; C, Rablb; D, Rab3a.  Inhibitor (10 p ~ ) :  H-Ras (shaded  box), 
G25K (speckled  box), Rablb (bold  hatched  box), Rab3a (black  box), a- 
factor peptide (light  hatched  box), and G protein y-6 subunit carboxyl- 
terminal hepapeptide (double  hatched  box). 
erab3a 
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FIG. 7. In vitro competition of Rablb and Rab3a  prenyla- 
tion. Substrate proteins (0.75 p ~ )  were incubated with reticulocyte 
lysate and [‘HIGGPP alone or in the presence of excess (IO p ~ )  
competing protein. Following incubation, proteins were resolved by 
SDS-PAGE and  fluorography. Lanes a and b, Rablb alone; lanes c- 
e, Rablb with excess Rab3a; lanes f-h, Rab3a alone; and lanes i-k, 
Rab3a with excess Rablb. 
or common geranylgeranyl transferase activities, the ability 
of excess full-length Rab  proteins to block isoprenylation of 
the corresponding Rab protein was determined. While Rablb 
isoprenylation was not  inhibited by  G25K or H-Ras proteins, 
geranylgeranylation of Rablb was inhibited (by 84%) when 
assayed in the presence of a 10-fold molar excess of Rab3a 
(Fig. 6C and Fig. 7, lanes c-e). Similarly, Rab3a geranylger- 
anylation was inhibited (by 93%) when assayed in  the pres- 
ence of a 10-fold molar excess of Rablb,  but  not  H-Ras or 
G25K proteins (Fig.  6D and Fig. 7, lanes Liz). This level of 
inhibition correlated well with that predicted by the respective 
K ,  values for these substrates (K,,, for Rablb = 1.0 PM; K ,  
for Rab3a = 2.3 PM) if their prenylation were catalyzed by 
the same enzyme(s). The predicted inhibition of Rablb pren- 
ylation by Rab3a under these  conditions is 71% and  that for 
Rab3a by Rablb is 88%. Thus these data suggest that  the CC 
and CXC proteins are recognized by the same geranylgeranyl 
transferase(s). 
DISCUSSION 
While the carboxyl-terminal CC and CXC sequences of Rab 
proteins are functionally analogous to the Ras CXXX se- 
quence in  that  they signal isoprenoid modification and pro- 
mote membrane association, three previous observations have 
suggested that  the sequence requirements for prenyl transfer- 
ase recognition and isoprenoid modification of Rab  proteins 
may be different from those of Ras and  other CXXX-contain- 
ing proteins. First, in  contrast  to  the ability of CXXX-con- 
taining peptides to  inhibit Ras isoprenylation, synthetic pep- 
tides containing the Rab CC or CXC sequences were not 
effective inhibitors of, nor substrates for, isoprenylation (11, 
28,29). Second, it  has been shown that  the noncysteine XXX 
residues of the CXXX motif are the critical residues for 
efficient recognition and modification by the CXXX prenyl 
transferases (11, 30, 53). Third, a mutant yeast Rasl protein 
that  terminated with the 6 carboxyl-terminal residues of yeast 
YPTl was not a substrate for GGTase I1 activity (11). Despite 
these indications, our observations that chimeric Ras/Rab 
proteins terminating in significant carboxyl-terminal se- 
quences from Rablb, Rab2, or Rab3a were not isoprenylated 
were unexpected. These  results clearly demonstrate that  the 
sequence requirements for Rab isoprenylation are strikingly 
different from those for isoprenylated proteins that terminate 
in CXXX sequences, and suggest that Rab geranylgeranyl 
transferase(s) requires recognition of sequences outside the 
Rab carboxyl termini, and possibly protein conformation, for 
isoprenoid modification. Whereas CXXX carboxyl-terminal 
sequences are both necessary and sufficient to signal isopren- 
oid modification, our  results indicate that multiple regions of 
the CC- and CXC-terminating  Rab  proteins combine to act 
as  structural determinants of the isoprenylation signal. 
Synthetic peptides corresponding to  the CXXX sequences 
of Ras  proteins have been very useful reagents for the iden- 
tification and analysis of CXXX farnesyl and geranylgeranyl 
transferases (10, 14, 16) and have allowed a rapid character- 
ization of the structural requirements for prenylation of 
CXXX-terminating  proteins (11, 53, 16). Ras  CXXX tetra- 
peptides are sufficient to both  inhibit Ras isoprenylation and 
to serve as  substrates for Ras farnesyl transferase activity (1 1, 
12, 53). Furthermore,  CXXX  tetrapeptides have also greatly 
facilitated the affinity purification of Ras prenyl transferases 
and have provided a basis for the design of potential inhibitors 
of oncogenic Ras activity in  human  tumors (10). By contrast, 
since prenylation of Rab proteins requires recognition of 
primary or higher order structure besides the carboxyl-ter- 
minal prenylation domain, such carboxyl-terminal peptides 
will be less useful for the characterization of Rab prenyl 
transferases. In particular, assays of Rab prenylation and 
determination of specific sequence requirements for reactivity 
of the Rab  substrates will require intact Rab proteins. Recent 
studies have identified geranylgeranyl transferase activities 
(designated GGTase I1 or Rab GGTase) for Rab proteins (1  1, 
28,  29) which are  distinct from the activity that geranylger- 
anylates  proteins that  terminate with CXXX sequences 
(GGTase I). The results from competition experiments de- 
scribed in this study demonstrated that  Rablb (CC motif) 
and Rab3a (CXC motif) were competitors of the isoprenyla- 
tion of the reciprocal protein  in  a reticulocyte lysate assay. 
These  results provide evidence that geranylgeranyl additions 
to CC or CXC terminating  proteins  are catalyzed by a com- 
mon geranylgeranyl transferase activity(ies). Additionally, 
the successful isoprenylation of mutant Rablb proteins in 
which CXC sequences replaces the authentic CC sequence 
suggests that  the CC and CXC motifs require common up- 
stream sequences, or protein conformation, for signaling ger- 
anylgeranyl addition. Finally, the recent demonstration that 
a  partially purified Rab3a geranylgeranyl transferase activity 
also efficiently modified Rabla is also consistent with a com- 
mon prenyl  transferase for these two motifs (29). Our obser- 
vation that  Rablb  mutants terminating  in  either  SC or CS 
24368 Rab CClCXC Motifs and  Isoprenylation 
are still geranylgeranylated are in agreement with results 
described by Kinsella  and  Maltese (32) and suggests that  the 
prenylation of the 2 cysteines  are  independent,  nonsequential 
reactions. Whether these two geranylgeranyl modifications 
are catalyzed by a single enzymatic activity remains to be 
determined. 
While it  is clear that  the  Ras C X X X  and  Rab CC or CXC 
motifs serve  analogous  roles in triggering  isoprenoid  modifi- 
cation  and  membrane  association (6), the  distinct processing 
signaled by each of these  motifs suggests the possibility of 
distinct roles in  regulating protein  function.  Proteins  termi- 
nating in C X X X  sequences are modified by either single 
farnesyl or geranylgeranyl moieties, and the isoprenylated 
cysteine also undergoes carboxyl methylation. In contrast, 
Rab  proteins  terminating  in CC or CXC sequences apparently 
undergo modification  by  geranylgeranyl  groups on  both cys- 
teines, but only the CXC proteins are further modified by 
carboxyl methylation. One aim of our studies has been to 
determine whether Ras function can be promoted by the 
modifications  signaled by the CC or CXC motifs. The  non- 
prenylated  and cytosolic nature of mutant  Ras  proteins  that 
terminate with CC or CXC sequences clearly indicate that 
these motifs alone do not functionally replace the C X X X  
motif for promoting  Ras  function. However, since  these  mu- 
tan t  proteins are not processed, how the function of Ras 
proteins  in  regulating  signal  transduction  pathways  in  the cell 
is facilitated by Rab  carboxyl-terminal modifications remains 
t o  be answered. 
At present,  there  is  limited  information available addressing 
whether  there  is a functional  basis for the  distinct  prenylation 
motifs.  Our  recent  observation  that  normal  Ras  proteins  that 
terminate  in  mutant C X X X  sequences  signaling  for geranyl- 
geranyl,  rather  than farnesyl, addition  are  potent  inhibitors 
of cell proliferation suggests a distinct role for distinct  pren- 
ylation motifs (54). In contrast, the observation that yeast 
YPT1, which is  essential for cell viability (43) and  facilitates 
endoplasmic reticulum (ER) to Golgi transport (55) ,  could 
still  support  yeast viability when  the CC motif is  substituted 
with  the  H-Ras C X X X  sequence ( C V L S )  might  argue  against 
a unique role for the different motifs in protein function. 
However, it was not determined whether this carboxyl-ter- 
minal  mutant was correctly  processed or  whether  it  retained 
wild type function in transport.  Therefore, at present,  it  is 
not known whether  the C X X X ,   C C ,  and CXC motifs possess 
distinct roles in  promoting  protein  function. Clearly, further 
analysis of this question will be required to establish the 
functional significance of different  carboxyl-terminal se- 
quences that signal protein prenylation. We have recently 
demonstrated the contribution of Rablb protein in ER to 
Golgi transport (33), and we are  presently  determining 
whether  mutant  Rablb  proteins  that  terminate in ither CXC 
or C X X X  sequences also  function  in ER  to Golgi transport. 
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